前田雄樹｜AnswersNews編集長

@answers_news · 東京港区 · joined 18 Mar 2016

“製薬業界で話題のニュースがよくわかる”ニュース解説メディア「AnswersNews」編集長。記者／編集者。全国紙記者→製薬業界紙記者→2016年にAnswersNews立ち上げ。雑誌などにも書いています。執筆などお仕事の依頼はお気軽にDMまで。ギター／キャンプ／ビール。※ツイートは個人の見解です。

57 704Followers

812Following

12 926Posts total

18.9KViews on collected posts

Son gönderiler

前田雄樹｜AnswersNews編集長@answers_news12 Sep

👀読まれています【会見ほぼ全文】中外製薬の研究者3人にラスカー賞…エミシズマブ創製「仲間と一緒に困難を乗り越えた先に患者の笑顔がある」 #AnswersNews https://t.co/N9m6VamQMV 6.7K views · 30 likes · 4 reposts · 0 replies Open on X →

前田雄樹｜AnswersNews編集長@answers_news12 Sep

【1週間振り返り】製薬業界今週の主なニュース（9月7日-9月11日） ▽9月11日（金）・厚労省・PMDA「Project Orbis」に正式参加・武田薬品元社長の長谷川閑史氏が死去・メディパルとJCR、ムコ多糖症IIIB型治療薬のグローバルP1/2試験開始など #AnswersNews https://t.co/tdbKwQzvbr 3.8K views · 9 likes · 1 reposts · 0 replies Open on X →

前田雄樹｜AnswersNews編集長@answers_news12 Sep

【1週間振り返り】製薬業界今週の主なニュース（9月7日-9月11日） ▽9月10日（木）・楽天メディカル、取締役副会長にクリストフ・ウェバー氏・生化学工業「SI-6603」米で再び承認見送り・「フィブラストスプレー」美容目的の使用確認、適正使用呼びかけ #AnswersNews https://t.co/N976vMpHzI 3.4K views · 4 likes · 0 reposts · 0 replies Open on X →

前田雄樹｜AnswersNews編集長@answers_news12 Sep

【1週間振り返り】製薬業界今週の主なニュース（9月7日-9月11日） ▽9月9日（水）・ElixとAxcelead DDP、タンパク質分解誘導薬の共同研究・帝人、信州大と細胞・遺伝子治療製品製造技術の共同研究・シミックHD、新卒採用にAIとの対話型選考を導入 #AnswersNews https://t.co/T2D5VvlFkz 2.7K views · 2 likes · 0 reposts · 0 replies Open on X →

前田雄樹｜AnswersNews編集長@answers_news12 Sep

【1週間振り返り】製薬業界今週の主なニュース（9月7日-9月11日） ▽9月8日（火）・メディパルHD、今川氏が社長に昇格…渡辺氏は会長に・MOLCURE、ペプチド創薬でAxcelead DDPと協業 #AnswersNews https://t.co/KYRhDv7quv 2.3K views · 1 likes · 0 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 5 gönderi, 10K–100K takipçi aralığıyla yan yana. geniş kitleye gösteriliyor, ama izleyenlerin azı tepki veriyor.

Medyan görüntülenme3 403bu hesap91710K–100K için medyan

Erişim, %5.90%bu hesap3.39%10K–100K için medyan

Etkileşim, %0.12%bu hesap1.53%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	3 403	917	3.71×
Erişim (görüntülenme ÷ takipçi)	5.90%	3.39%	1.74×
Etkileşim oranı	0.12%	1.53%	0.08×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.3K12 Sep

2.7K

3.4K

3.8K

6.7K

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.04%12 Sep

0.08%

0.12%

0.26%

0.51%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.53%.

What the audience does

Likes86.8%46 in total

Reposts9.4%5 in total

Bookmarks3.8%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar